Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic

Respiratory tract infection is one of the most frequent and fatal infections in the geriatric population. Long-term Care Facilities (LTCF) residents are prone to infection because of the decrease in their immunity, their impaired cognitive function, frailty, congregated setting, the kinds of medication taken, and the presence of many underlying factors like diabetes or kidney

By |2021-07-07T11:45:38-04:00July 7th, 2021|Categories: Quarterly Letter|Comments Off on Letter from the Director: Biofire Respiratory 2.1 Panel helps tackle infections during pandemic

Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production

Published December 2020 as part of Aculabs’ LabTalk quarterly newsletter. Aculabs will be offering a Reticulocyte Comprehensive Panel – the panel can provide comprehensive information needed by physicians to assess the rate of red cell production and hemoglobinization. Reticulocyte count (RET #, %) indicates the quantity of circulating reticulocytes. The Immature Reticulocyte Fraction (IRF) indicates

By |2020-12-29T15:52:56-05:00December 29th, 2020|Categories: Quarterly Letter|Comments Off on Letter from the Director: Reticulocyte Comprehensive Panel assists in assessing red blood cell production

Letter from the Director: Understanding Antibody Testing Provided by Aculabs

Antibodies are proteins produced by the immune system in response to infection, often within the first week of post-symptoms onset. There are several forms of antibodies: IgG, IgM, IgA, as well as other forms. However, not all antibodies are created equal; some are considered to be binding antibody and some are neutralizing. A neutralizing

By |2021-01-26T10:25:55-05:00December 29th, 2020|Categories: Quarterly Letter|Comments Off on Letter from the Director: Understanding Antibody Testing Provided by Aculabs

Letter from the Director: Biotin Influence on Laboratory Immunoassay Tests

Published September 2018 as part of Aculabs' LabTalk quarterly newsletter. Laboratory errors have been reported to be 0.012-0.6%; errors due to interference are less than 0.078%. One of the causes of interference in a laboratory is Biotin. - National Institutes of Health's Office of Dietary Supplements. Biotin, known as vitamin B7 or vitamin

By |2020-12-29T15:50:20-05:00September 25th, 2018|Categories: Quarterly Letter|0 Comments

Letter from the Director: Postural Pseudoanemia in Long-Term Care Facilities

Published July 2018 as part of Aculabs' LabTalk quarterly newsletter. Anemia is very common in the geriatric population; several studies have shown that the prevalence of anemia increases with advancing in age, the increase start at the age of 65 and rises sharply after the age of 80. To diagnose anemia, physicians rely heavily on

By |2018-09-25T12:41:21-04:00July 26th, 2018|Categories: Quarterly Letter|0 Comments

Letter from the Director: Understanding the H1N1 Virus

Originally published in LabTalk (Volume 4, Issue 3, 2009), the quarterly newsletter of Aculabs. Novel H1N1 virus, known to be an influenza A-subtype, was originally referred to as “swine flu” because it is very similar to influenza viruses normally occurring in North American pigs (swine). Flu viruses are mainly spread from person to person through

By |2018-09-19T12:14:19-04:00September 30th, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: Accurate Diagnosis Benefits of 25-Hydroxyvitamin D

Originally published in LabTalk (Volume 4, Issue 2, 2009), the quarterly newsletter of Aculabs. Vitamin D has been well known for its role in bone metabolism; however, the important role of vitamin D beyond that was the discovery of the 1,25-Dihydroxyvitamin D nuclear receptor in most tissue. Increased interest in vitamin D introduced the recent

By |2018-07-26T15:56:37-04:00June 30th, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: High Sensitivity C-Reactive Protein & Statin Treatments

Originally published in LabTalk (Volume 4, Issue 1, 2009), the quarterly newsletter of Aculabs. JUPITER (Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin), a study published in the Nov. 20 edition of New England Journal of Medicine, showed that treatment with Statin could significantly reduce cardiovascular problems in apparently

By |2018-09-19T12:11:01-04:00January 31st, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: Prostate Cancer Awareness & Diagnosis

Originally published in LabTalk (Volume 3, Issue 4, 2008), the quarterly newsletter of Aculabs. September was “National Prostate Cancer Awareness Month.” The goal of this annual event is to generate widespread awareness regarding prostate cancer and to give the public an opportunity to learn more about it and how to reduce their risk. Prostate cancer

By |2018-07-26T15:57:02-04:00December 31st, 2008|Categories: Quarterly Letter|0 Comments

Letter from the Director: Prothrombin Time Tests & Blood Clotting

Originally published in LabTalk (Volume 3, Issue 3, 2008), the quarterly newsletter of Aculabs. Prothrombin time (PT) tests measure clotting time in a blood sample from the activation of factor VII through the formation of fibrin clot. PT evaluates the integrity of the extrinsic and common pathways of coagulation. It is measured in seconds and

By |2018-07-26T15:57:14-04:00September 30th, 2008|Categories: Quarterly Letter|0 Comments
Go to Top